Quantum computing in 2025: from dream to deployment
Quantum computing has moved from theory and science fiction to become a strategy for business growth, with transformative rewards for those willing to engage with its complexities
Primary care diagnostics are key to addressing antimicrobial resistance
Primary care is the hidden battlefield of antimicrobial resistance. It is here that more than 80% of all antibiotics are prescribed. Our experts are tackling the challenge of equipping primary care physicians with the right diagnostic and decision-making solutions
A potential gamechanger for the treatment of keratoconus
Deep tech consultants at Cambridge Consultants report on a potential gamechanger for the treatment of keratoconus, a challenging degenerative eye condition.
From stealth mode to the shock of the new – how deep tech can boost company valuation
Why is deep tech important? What defines deep tech, and how to value deep tech companies? With stealth and surprise, deep tech can boost company valuation.
Our people-centric design innovation is recognised on the global awards stage
An AstraZeneca concept collaboration is one of three projects by deep tech consultants at Cambridge Consultants to receive prestigious iF DESIGN AWARDS
Generative biology breakthrough from Capgemini – PharmaTimes
Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes